Literature DB >> 20446123

Modern approaches to the diagnosis and treatment of cold contact urticaria.

Karoline Krause1, Torsten Zuberbier, Marcus Maurer.   

Abstract

Cold contact urticaria (CCU) is a common subtype of physical urticaria characterized by itchy wheals and/or angioedema due to skin mast cell activation and the release of proinflammatory mediators after cold exposure. The underlying causes are largely unknown. When CCU is suspected, cold stimulation tests and threshold testing should be done to confirm the diagnosis and to determine the severity and course of CCU, respectively. Avoidance of critical cold exposure should be recommended but is often impossible, especially for severely affected patients with high temperature and low exposure time thresholds. Symptomatic treatment of choice is the use of modern, nonsedating antihistamines. Patients should be informed that complete protection from CCU symptom development may require increased doses of antihistamines. Standardizing cold provocation tests and further characterization of the natural course of CCU and its variants may lead to a better understanding of the disease-driving mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20446123     DOI: 10.1007/s11882-010-0121-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  54 in total

1.  Association of platelet-activating factor with primary acquired cold urticaria.

Authors:  K E Grandel; R S Farr; A A Wanderer; T C Eisenstadt; S I Wasserman
Journal:  N Engl J Med       Date:  1985-08-15       Impact factor: 91.245

2.  Delayed cold urticaria.

Authors:  C N Matthews; R P Warin
Journal:  Br J Dermatol       Date:  1977-07       Impact factor: 9.302

3.  A case study on the induction of clinical tolerance in cold urticaria.

Authors:  T M Keahey; J Indrisano; M A Kaliner
Journal:  J Allergy Clin Immunol       Date:  1988-08       Impact factor: 10.793

4.  Treatment of cold urticaria with cyproheptadine.

Authors:  A A Wanderer; E F Ellis
Journal:  J Allergy Clin Immunol       Date:  1971-12       Impact factor: 10.793

5.  In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling.

Authors:  A P Kaplan; M A Beaven
Journal:  J Invest Dermatol       Date:  1976-09       Impact factor: 8.551

6.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Authors:  Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil Stahl; Scott J Mellis
Journal:  Arthritis Rheum       Date:  2008-08

7.  Essential IgG cryoglobulinemia with purpura and cold urticaria.

Authors:  H Koda; A Kanaide; M Asahi; H Urabe
Journal:  Arch Dermatol       Date:  1978-05

8.  Tumor necrosis factor-alpha release during systemic reaction in cold urticaria.

Authors:  I Tillie-Leblond; P Gosset; A Janin; R Dalenne; M Joseph; B Wallaert; A B Tonnel
Journal:  J Allergy Clin Immunol       Date:  1994-02       Impact factor: 10.793

9.  Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study.

Authors:  A Katsarou-Katsari; M Makris; E Lagogianni; S Gregoriou; T Theoharides; D Kalogeromitros
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-12       Impact factor: 6.166

10.  Acquired cold urticaria symptoms can be safely prevented by ebastine.

Authors:  M Magerl; J Schmolke; F Siebenhaar; T Zuberbier; M Metz; M Maurer
Journal:  Allergy       Date:  2007-09-26       Impact factor: 13.146

View more
  8 in total

1.  Cold-induced urticaria: challenges in diagnosis and management.

Authors:  Elana Fay Hochstadter; Moshe Ben-Shoshan
Journal:  BMJ Case Rep       Date:  2013-07-08

Review 2.  Physical urticaria.

Authors:  Marina Abajian; Agnieszka Młynek; Marcus Maurer
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

3.  [Cold-induced urticaria and angioedema. Classification, diagnosis and therapy].

Authors:  K Krause; F Degener; S Altrichter; E Ardelean; D Kalogeromitros; M Magerl; M Metz; F Siebenhaar; K Weller; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

4.  Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response.

Authors:  Justin R Yu; Kieron S Leslie
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

Review 5.  Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis.

Authors:  Duraisamy Kempuraj; Govindhasamy P Selvakumar; Ramasamy Thangavel; Mohammad E Ahmed; Smita Zaheer; Sudhanshu P Raikwar; Shankar S Iyer; Sachin M Bhagavan; Swathi Beladakere-Ramaswamy; Asgar Zaheer
Journal:  Front Neurosci       Date:  2017-12-12       Impact factor: 4.677

6.  Management of chronic urticaria in children: a clinical guideline.

Authors:  Carlo Caffarelli; Francesco Paravati; Maya El Hachem; Marzia Duse; Marcello Bergamini; Giovanni Simeone; Massimo Barbagallo; Roberto Bernardini; Paolo Bottau; Filomena Bugliaro; Silvia Caimmi; Fernanda Chiera; Giuseppe Crisafulli; Cristiana De Ranieri; Dora Di Mauro; Andrea Diociaiuti; Fabrizio Franceschini; Massimo Gola; Amelia Licari; Lucia Liotti; Carla Mastrorilli; Domenico Minasi; Francesca Mori; Iria Neri; Aurelia Pantaleo; Francesca Saretta; Carlo Filippo Tesi; Giovanni Corsello; Gian Luigi Marseglia; Alberto Villani; Fabio Cardinale
Journal:  Ital J Pediatr       Date:  2019-08-15       Impact factor: 2.638

7.  Treatment of severe cold contact urticaria with omalizumab: case reports.

Authors:  Petra Brodská; Peter Schmid-Grendelmeier
Journal:  Case Rep Dermatol       Date:  2012-12-20

8.  Effects of a Moderately Lower Temperature on the Proliferation and Degranulation of Rat Mast Cells.

Authors:  Ruoyu Wang; Xiaoqin Yin; Hui Zhang; Jiwei Wang; Lin Chen; Jingwen Chen; Xiaodong Han; Zou Xiang; Dongmei Li
Journal:  J Immunol Res       Date:  2016-04-18       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.